Authors: CHLEBUS E WOLSKA H BLASZCZYK M JABLONSKA S

Citation: E. Chlebus et al., SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS VERSUS SYSTEMIC LUPUS-ERYTHEMATOSUS - DIAGNOSTIC-CRITERIA AND THERAPEUTIC IMPLICATIONS, Journal of the American Academy of Dermatology, 38(3), 1998, pp. 405-412

Authors: BOS JD WITKAMP L ZONNEVALD IM RUZICKA T SZARMACH H SZCZERKOWSKADOBOSZ A RUBINS AY HARTMANE I BLASZCYK M WOLSKA H WASIK F BIALYNICKIBIRULA R

Citation: Jd. Bos et al., SYSTEMIC TACROLIMUS (FK-506) IS EFFECTIVE FOR THE TREATMENT OF PSORIASIS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Archives of dermatology, 132(4), 1996, pp. 419-423

Authors: WOLSKA H LAWS S SCHULZKIESOW M GROSSMAN R JABLONSKA S STADLER R VANDEKERKHOF PCM DUPUY P

Citation: H. Wolska et al., CLINICAL-EVALUATION OF A PAF-ANTAGONIST IN PSORIASIS-VULGARIS, Journal of dermatological treatment, 6(1), 1995, pp. 43-45

Authors: LANGNER A STAPOR V WOLSKA H VERJANS H ELZERMAN JR

Citation: A. Langner et al., COMBINED TREATMENT OF CHRONIC PLAQUE PSORIASIS WITH ETRETINATE AND TOPICAL 1,25-DIHYDROXYVITAMIN D-3, Journal of dermatological treatment, 6(1), 1995, pp. 53-53

Authors: BEUTNER EH BLASZCZYK M JABLONSKA S CHORZELSKI TP WHITE D WOLSKA H DAVIS B

Citation: Eh. Beutner et al., PRELIMINARY, DERMATOLOGICAL 1ST STEP CRITERIA FOR LUPUS-ERYTHEMATOSUSAND 2ND STEP CRITERIA FOR SYSTEMIC LUPUS-ERYTHEMATOSUS, International journal of dermatology, 32(9), 1993, pp. 645-651